4Moving Biotech is a biopharmaceutical company that develops osteoarthritis drugs for osteoarthritis patients.
4Moving Biotech has raised $14.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
4Moving Biotech's investors include France 2030.
4Moving Biotech is headquartered in Lille, France.
4Moving Biotech is a biopharmaceutical company that develops osteoarthritis drugs for osteoarthritis patients.
4Moving Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"4Moving Biotech — Funding & Investors." VCBacked, February 10, 2026, https://www.vcbacked.co/company/4moving-biotech. Accessed August 13, 2026.
VCBacked. (2026). 4Moving Biotech — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/4moving-biotech
{{cite web |title=4Moving Biotech — Funding & Investors |url=https://www.vcbacked.co/company/4moving-biotech |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated